Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia Rheumatica
Launched by UNIVERSITY HOSPITAL, BREST · Aug 14, 2024
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special imaging test called 18-FDG PET-CT to see how well it can help doctors diagnose a condition known as Polymyalgia Rheumatica, which is a type of inflammatory rheumatism. The researchers want to compare the results of this test with other similar diseases to understand its effectiveness better.
To participate in this study, you need to be an adult who has had an 18-FDG PET-CT scan between 2012 and 2024 and has been diagnosed with inflammatory rheumatism by a specialist. You should also be part of the social security system and agree to allow your medical data to be used for research. If you decide to join, you will help researchers learn more about using this imaging technique for diagnosing Polymyalgia Rheumatica, but if you choose not to participate or are under legal protection, you won't be eligible for the study. The trial is not yet recruiting participants, so there is no immediate action required at this time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having 18-FDG PET-CT between 2012 and 2024
- • Diagnosis of inflammatory rheumatism by specialist doctor
- • Adult without opposition to use there data for research
- • Affiliate to social security system
- Exclusion Criteria:
- • Refusal participation
- • Patient under juridic protection
About University Hospital, Brest
The University Hospital of Brest is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. With a strong emphasis on interdisciplinary collaboration, the hospital serves as a hub for cutting-edge clinical trials aimed at improving treatment outcomes across various medical specialties. Leveraging its robust academic affiliations and state-of-the-art facilities, the University Hospital of Brest is committed to fostering scientific discovery and enhancing the quality of life for patients through evidence-based practices and pioneering research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brest, , France
Patients applied
Trial Officials
Solène QUERELLOU
Study Director
CHU Brest
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported